Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome

BACKGROUND: Down syndrome (DS) individuals, by the age of 40s, are at increased risk to develop Alzheimer-like dementia, with deposition in brain of senile plaques and neurofibrillary tangles. Our laboratory recently demonstrated the disturbance of PI3K/AKT/mTOR axis in DS brain, prior and after the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Neurodegener
Main Authors: Tramutola, Antonella, Lanzillotta, Chiara, Barone, Eugenio, Arena, Andrea, Zuliani, Ilaria, Mosca, Luciana, Blarzino, Carla, Butterfield, D. Allan, Perluigi, Marzia, Di Domenico, Fabio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6218962/
https://ncbi.nlm.nih.gov/pubmed/30410750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-018-0133-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados